SCHEMBL5698534

SCHEMBL5698534

Cn1ccnc1-c1ccc(C=Nc2ccccc2)cc1[N+](=O)[O-]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.43
CYP2C19 P33261 3/20 0.43
CYP2D6 P10635 2/20 0.43
CYP2C9 P11712 2/20 0.43
ALDH1A1 P00352 9/20 0.43
MAPT P10636 10/20 0.42
KDM4E B2RXH2 4/20 0.42
MEN1 O00255 6/20 0.42
KMT2A Q03164 6/20 0.42
HTT P42858 4/20 0.42
HPGD P15428 4/20 0.42
LMNA P02545 2/20 0.42
MAPK1 P28482 1/20 0.42
CYP1A2 P05177 3/20 0.38
BRD4 O60885 1/20 0.38
TDP1 Q9NUW8 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
GAA P10253 2/20 0.36
PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5698528 1.00 CYP3A4 (0.43) CYP3A4CYP2C19CYP2D6CYP2C9ALDH1A1
SCHEMBL8010356 0.76 BRD4 (0.50) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL444243 0.64 PTGS2 (0.65) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL444244 0.64 PTGS2 (0.65) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL12416900 0.64 MAPT (0.57) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL24195093 0.64 MEN1 (0.71) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL4727410 0.61 MAPT (0.65) CYP3A4CYP2C19CYP2D6CYP2C9ALDH1A1
SCHEMBL10478287 0.61 MAPT (0.65) CYP3A4CYP2C19CYP2D6CYP2C9ALDH1A1
SCHEMBL8970543 0.60 KMT2A (0.42) CYP2D6ALDH1A1MAPTKDM4EMEN1
SCHEMBL8970537 0.60 KMT2A (0.42) CYP2D6ALDH1A1MAPTKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005044194-A2 TREATMENT OR PREVENTION OF NEOPLASIA BY USE OF AN Hsp90 INHIBITOR PHARMACIA CORPORATION (US) 2005-05-19 WO claimed
EP-1682143-A2 COMBINATIONS COMPRISING AN HSP90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA Pharmacia Corporation (US) 2006-07-26 EP disclosed
WO-2005044194-A2 TREATMENT OR PREVENTION OF NEOPLASIA BY USE OF AN Hsp90 INHIBITOR PHARMACIA CORPORATION (US) 2005-05-19 WO disclosed
WO-2005041879-A2 COMBINATIONS COMPRISING AN Hsp90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA PHARMACIA CORPORATION (US) 2005-05-12 WO disclosed